Goldman Sachs
-
The pair performed well in parts of their second quarter results, with better than expected performance in equity and debt underwriting -
World's largest chipmaker brings out its second bond of the year
-
-
GSK’s consumer health business trades down on London debut
-
2015 record of 25 deal-less days is soon to fall
-
New issue concessions on the rise in final major week of issuance before expected summer lull
-
As the threat of delisting continues to loom over US-listed Chinese companies, more are gravitating towards a listing in Hong Kong
-
Dealmakers are bullish despite pulled deals reaching a five year high amid financing headwinds and a looming recession, writes David Rothnie
-
Lifestyle company and wealth manager test investor appetite
-
Volatile debt markets continue to punish SSA issuers across the spectrum
-
De Nora has achieved a valuation of €2.72bn
-
Under the barren surface, the pipeline of deals is growing steadily
